STOCK TITAN

AbbVie to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AbbVie (NYSE: ABBV) is set to participate in the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 2:45 p.m. CT. Key executives, including Robert A. Michael, Michael E. Severino, M.D., and Jeffrey R. Stewart, will present virtually. A live audio webcast will be accessible on AbbVie's Investor Relations website, with an archived session available later that day. AbbVie focuses on innovative medicines across various therapeutic areas including immunology and oncology.

Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., Jan. 4, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. Members of AbbVie's executive leadership team will present virtually at 2:45 p.m. CT, including Robert A. Michael, vice chairman, finance and commercial operations and chief financial officer, Michael E. Severino, M.D., vice chairman and president, and Jeffrey R. Stewart, executive vice president, chief commercial officer.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

 

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301451930.html

SOURCE AbbVie

FAQ

When is AbbVie's presentation at the J.P. Morgan Healthcare Conference?

AbbVie will present on January 11, 2022, at 2:45 p.m. CT.

Who are the key executives presenting for AbbVie at the conference?

The key executives presenting are Robert A. Michael, Michael E. Severino, M.D., and Jeffrey R. Stewart.

How can I access AbbVie's presentation at the J.P. Morgan Healthcare Conference?

You can access a live audio webcast of the presentation on AbbVie's Investor Relations website.

What is the focus of AbbVie's business?

AbbVie focuses on innovative medicines in areas like immunology, oncology, and neurology.

Will there be a recording of AbbVie's presentation available?

Yes, an archived edition of AbbVie's presentation will be available later on the same day.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

292.69B
1.77B
0.09%
73.43%
0.92%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NORTH CHICAGO